Robert Plesnarski


Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.


Rob Plesnarski represents public and private companies, investment banks, private equity funds, hedge funds and other market participants in a full range of regulatory and transactional securities law matters.

Rob provides securities law regulatory advice to issuers, underwriters and institutional investors in US and international public and private offerings of equity, debt and derivative securities, with a particular focus on transactions involving equity derivatives or restricted or control securities. Rob also counsels Fortune 100 corporations, small public companies, investment funds and other clients in connection with federal and state securities law topics, including SEC disclosure best practices, corporate governance, beneficial ownership reporting under Sections 13 and 16 of the Exchange Act, SEC rules related to federal proxy matters, mergers and acquisitions and tender offers, and SEC enforcement matters. Rob regularly provides securities law advice with respect to the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, the Investment Advisors Act of 1940, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, and the JOBS Act.

Rob is consistently selected for inclusion as a top lawyer in Chambers USA, with Chambers noting that Rob “came highly recommended by sources, with several stressing his strength of substantive knowledge and his excellent rapport with clients” and that "on extremely complex issues, he's been phenomenal."


Corporate & Government Experience

  • Deputy Chief Counsel, United States Securities & Exchange Commission

Honors & Awards

  • Top Ranked Securities Regulation: Nationwide, Chambers USA
  • SEC Capital Markets Award


Bar Admissions

  • District of Columbia
  • Pennsylvania


  • Temple University, J.D., 1991: cum laude; Temple Law Foundation Scholarship 
  • Dartmouth College, B.A., 1987: magna cum laude

Professional Activities

Board of Advisors


Press Releases

Alerts and Publications

SEC Adopts Amendments to MD&A and Financial Disclosures

December 1, 2020

The SEC’s Most Recent No-Action Letter on Digital Assets—Is the SEC Moving Beyond a Closed Box for Digital Asset Issuers?

November 24, 2020

SEC Adopts Changes to Harmonize Private Offering Exemptions

November 19, 2020

SEC Amends “Accredited Investor” and “Qualified Institutional Buyer” Definitions under the Securities Act

September 8, 2020

SEC Adopts Changes to Modernize Certain Disclosures Under Regulation S-K

September 2, 2020

SEC Adopts Amendments to Proxy Rules Relating to Proxy Voting Advice

August 5, 2020

SEC Adopts Amendments Related to Financial Disclosures for Acquisitions and Dispositions

June 1, 2020

SEC Adopts Amendments to Accelerated Filer and Large Accelerated Filer Definitions

April 17, 2020

SEC Proposes Changes to Harmonize Private Offering Exemptions

March 30, 2020

SEC Extends Filing Relief and Provides Disclosure Guidance in Response to COVID-19

March 25, 2020

Companies Should Consider Adopting Net Operating Loss Rights Plans in the Wake of the Coronavirus (COVID-19) to Protect Net Operating Losses

March 20, 2020

SEC Amends Financial Disclosure Requirements for Registered Debt Offerings

March 17, 2020

SEC Proposes Amendments to MD&A and Financial Disclosures and Issues MD&A Interpretive Guidance

February 13, 2020

In the News